We use our own and third-party cookies to optimize your experience on this site, including to maintain user sessions. Without these cookies our site will not function well. If you continue browsing our site we take that to mean that you understand and accept how we use the cookies. If you wish to decline our cookies we will redirect you to Google.
Already have an account? Sign in.

 Remember Me | Forgot Your Password?

Omega-3 Fatty Acid DHA Proves More Useful In Treating Fatty Liver Disease – Study

February 5, 2013: 12:00 AM EST
A U.S. study in lab animals comparing two omega-3 fatty acids finds that onehad the greatest effect on nonalcoholic fatty liver disease. Researchers report that EPA did little to prevent the scarring (fibrosis) associated with nonalcoholic steatohepatitis (NASH). DHA supplementation, however, reduced the proteins involved in liver fibrosis by more than 65 percent. Liver inflammation and fibrosis are common problems growing steadily as the obesity problem worsens among Americans. "Based on these results, DHA may be a more attractive dietary supplement than EPA for the prevention and potential treatment of NASH in obese humans," researchers concluded.
"Some omega-3 oils better than others for protection against liver disease", Oregon State University, February 05, 2013, © Oregon State University
Food & Nutrition
Pills & Supplements
North America
United States of America
Research, Studies, Advice
Developed by Yuri Ingultsov Software Lab.